Teneligliptin 20mg + Metformin Hydrochloride 500mg (Prolonged Release) is a combination oral medication designed for the effective management of type 2 diabetes mellitus. Teneligliptin, a DPP-4 inhibitor, helps regulate blood sugar by enhancing the incretin effect, which increases insulin secretion and decreases glucagon levels in a glucose-dependent manner. Metformin Hydrochloride (Prolonged Release) improves insulin sensitivity, reduces hepatic glucose production, and controls postprandial and fasting blood glucose levels. The prolonged-release formulation ensures gradual absorption, maintaining stable blood sugar levels over an extended period and improving patient compliance. This combination therapy is ideal for patients whose blood glucose levels are not adequately controlled by diet, exercise, or monotherapy. It provides dual-action glucose control while reducing the risk of hypoglycemia when used appropriately.
